- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩393,000.00
7D
-5.8%
1Y
-41.8%
Samsung BiologicsLtd
Market Cap: ₩70.8t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,531,000.00
7D
-4.8%
1Y
-2.8%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩36,600.00
7D
-2.1%
1Y
8.6%
JW Shinyak
Market Cap: ₩123.8b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,215.00
7D
-2.9%
1Y
51.1%
JW Holdings
Market Cap: ₩282.0b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,075.00
7D
0.4%
1Y
22.2%
SK Biopharmaceuticals
Market Cap: ₩6.7t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩85,200.00
7D
-5.9%
1Y
-12.8%